AII
DGX icon

AGF Investments Inc’s Quest Diagnostics DGX Stock Holding History

AGF Investments Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,244
Closed -$388K – 506
2021
Q4 		$388K Buy
2,244
+1,044
+87% +$159K ﹤0.01% 509
2021
Q3 		$174K Sell
1,200
-158
-12% -$23.1K ﹤0.01% 616
2021
Q2 		$179K Buy
+1,358
New +$178K ﹤0.01% 628
2020
Q2 		– Sell
-2,626
Closed -$211K – 830
2020
Q1 		$211K Buy
+2,626
New +$272K ﹤0.01% 579
2014
Q4 		– Sell
-100
Closed -$6K – 388
2014
Q3 		$6K Hold
100
– – ﹤0.01% 381
2014
Q2 		$6K Hold
100
– – ﹤0.01% 383
2014
Q1 		$6K Hold
100
– – ﹤0.01% 406
2013
Q4 		$5K Buy
+100
New +$5.93K ﹤0.01% 414

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

AGF Investments Inc's DGX Position: Q1 2022 in Review

AGF Investments Inc sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 2,244 shares — an estimated $388K sold.

AGF Investments Inc first reported a position in DGX in Q4 2013 and held it in 8 quarters. The position peaked at $388K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • AGF Investments Inc reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 2,244 Quest Diagnostics shares in Q1 2022, an estimated $388K.
  • AGF Investments Inc first reported a position in Quest Diagnostics in Q4 2013 and held it in 8 quarters.
  • AGF Investments Inc's Quest Diagnostics position peaked at $388K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.